Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
about
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Chronic kidney disease: targeting prostaglandin E2 receptors.Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.
P2860
Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@en
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@nl
type
label
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@en
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@nl
prefLabel
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@en
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@nl
P2093
P2860
P356
P1433
P1476
Celecoxib modifies glomerular ...... ibuprofen is more detrimental.
@en
P2093
Jacob Karsh
Rania Nasrallah
Richard L Hébert
Susan J Robertson
P2860
P304
P356
10.1042/CS20120543
P407
P577
2013-06-01T00:00:00Z